DrugPatentWatch Database Preview
Drugs in Development Information for Seltorexant
Email this page to a colleague
» See Plans and PricingWhat is the drug development status for Seltorexant?
Seltorexant is an investigational drug.
There have been 6 clinical trials for Seltorexant.
The most recent clinical trial was a Phase 1 trial, which was initiated on September 1st 2017.
The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Janssen Research & Development, LLC, Minerva Neurosciences, and [disabled in preview].
There are three US patents protecting this investigational drug and fifty-eight international patents.
Summary for Seltorexant
| US Patents | 3 |
| International Patents | 58 |
| US Patent Applications | 6 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2017-09-01) |
| Vendors | 7 |
Recent Clinical Trials for Seltorexant
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder | Janssen Research & Development, LLC | Phase 1 |
| A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea | Janssen Research & Development, LLC | Phase 1 |
| A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants | Minerva Neurosciences | Phase 1 |
Clinical Trial Summary for Seltorexant
Top disease conditions for Seltorexant
Top clinical trial sponsors for Seltorexant
US Patents for Seltorexant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Seltorexant | Start Trial | Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators | Janssen Pharmaceutica (BE) | Start Trial |
| Seltorexant | Start Trial | Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators | Janssen Pharmaceutica NV (BE) | Start Trial |
| Seltorexant | Start Trial | Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators | Janssen Pharmaceutica NV (Beerse, BE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Seltorexant
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Seltorexant | Argentina | 078731 | 2029-10-23 | Start Trial |
| Seltorexant | Australia | 2010310595 | 2029-10-23 | Start Trial |
| Seltorexant | Australia | 2015242975 | 2029-10-23 | Start Trial |
| Seltorexant | Brazil | 112012010820 | 2029-10-23 | Start Trial |
| Seltorexant | Canada | 2778484 | 2029-10-23 | Start Trial |
| Seltorexant | Chile | 2010001162 | 2029-10-23 | Start Trial |
| Seltorexant | China | 102781942 | 2029-10-23 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
